
Rejuveron Life Sciences: A biotech platform investing in innovative therapies for healthy aging.
Rejuveron Life Sciences is a biotechnology platform company dedicated to developing and investing in therapies that target geriatric diseases. The company's mission is to expand healthspan, promoting overall health, well-being, and longevity as the population ages. Rejuveron brings together experienced pharma drug developers, visionary longevity scientists, and strong business leaders to transform promising discoveries in aging research into effective therapies.
Rejuveron has made significant strides in the biotech industry by focusing on innovative solutions for healthy aging. The company has successfully integrated a diverse team of experts to drive its mission forward, creating impactful therapies that address the challenges of aging. Through strategic investments and a commitment to scientific excellence, Rejuveron aims to make a lasting impact on public health and longevity.

Juvenescence
juvlabs.com

Rejuvenation Technologies Inc.

Longeveron
longeveron.com

Retro Biosciences
retro.bio

Rejuvenate Bio
rejuvenatebio.com

Regenerative Bio
regen-bio.us

Rejuvitas
rejuvitas.com

Gerostate Alpha

Lifespan Vision Ventures

Cambrian BioPharma
cambrianbio.com

BioAge Labs
bioagelabs.com

Rubedo Life Sciences
rubedolife.com

AgeX Therapeutics

Humanity
humanity.email

Oisin Biotechnologies
oisinbio.com
Companies similar to Rejuveron Life Sciences include Juvenescence, Rejuvenation Technologies Inc., Longeveron and Retro Biosciences.
Rejuveron Life Sciences was founded in 2019.
Rejuveron Life Sciences' headquarters is located in Schlieren, Zürich, CH.
As of Sep 13, 2023, Rejuveron Life Sciences has raised a total of $97.6M (USD).
Rejuveron Life Sciences has 22 employees as of Feb 10, 2024.